wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38658328-4B3B5031-BED7-4D7A-B4E6-6FA5461F9471
Q38658328-4B3B5031-BED7-4D7A-B4E6-6FA5461F9471
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38658328-4B3B5031-BED7-4D7A-B4E6-6FA5461F9471
Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease.
P2860
Q38658328-4B3B5031-BED7-4D7A-B4E6-6FA5461F9471
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38658328-4B3B5031-BED7-4D7A-B4E6-6FA5461F9471
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
74e9f1fe1a89fcc54d85d447be6f4f42b2d233d6
P2860
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.